[New research project: SCORE2 risk model to clinical practice in Asia and Oceania]

Asian Pacific Society of Cardiology(APSC)에서 진행하는 'New research project: SCORE2 risk model to clinical practice in Asia and Oceania'와 관련하여 안내 드립니다. 해당 프로젝트를 통해 SCORE2 Risk Model을 아시아/오세아니아 지역 임상에 적용할 예정이며, 검증 진행을 위하여 데이터 요청을 주셨습니다.

[요청 데이터]

1번째 단계 (Recalibration)

national registry data ideally, have at least 10-years of follow-up, baseline information on age, sex, history of CVD, median baseline date of data collection after 2000, recorded cause-specific deaths and non-fatal cardiovascular disease events

2번째 단계 (external validation)

population-based (ie, did not select participants on the basis of having previous disease), did not comprise of active treatment arms of clinical trials, and have recorded cause-specific deaths and non-fatal cardiovascular disease events
Needs at least 1-year of follow-up, and ideally 10. Will also need baseline information on age, sex, smoking status, history of diabetes mellitus, systolic blood pressure, total and HDL cholesterol

**이와 관련하여 관심이 있으신 선생님께서는 사무국(herz9@circulation.or.kr)으로 문의 바랍니다.